Neoplasia/BPH

	Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features. Prostate Shimomura T, Murakami M, Kasai K, Imai Y, Inaba Y, Urabe F, Muramoto K, Yanagisawa T, Fukuokaya W, Keiichiro Mori, Tashiro K, Matsukawa A, Katsumi K, Takahashi H, Yoshihara K, Miyajima K, Iwatani K, Kayano S, Igarashi T, Tsuzuki S, Yamada H, Miki J, Kimura T. PMID: 41995698 [PubMed - as supplied by publisher]
	Predictive factors for the development of urethral stricture in patients undergoing holmium laser enucleation of the prostate: A retrospective study. Medicine (Baltimore) Efendio, Özcan C, Tokatli Z. PMID: 41995549 [PubMed - indexed for MEDLINE]
	A nurse-led cross-sectional latent profile analysis of fear of cancer recurrence in patients with non-muscle-invasive bladder cancer. Medicine (Baltimore) Hao Y, Niu L, Shih YA, Gao P, Wu Y, Song W, Li C. PMID: 41995514 [PubMed - indexed for MEDLINE]
	Analysis of Clavien-Dindo classification and risk factors for complications after transurethral Thulium Laser enucleation of the prostate. Medicine (Baltimore) Zuo C, Gao W, Meng Y, Yang K, Zhang M, Meng X, Zhang K. PMID: 41995486 [PubMed - indexed for MEDLINE]
	Early recurrence after primary TURBT for non-muscle-invasive bladder cancer in Iceland: the critical role of surgical quality. Scand J Urol Björnsson O, Geirsson G, Leifsson ÁS, Nikulásson SÞ, Guðjónsson S. PMID: 41995346 [PubMed - indexed for MEDLINE]
	Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancer. Scand J Urol Mesinovic D, Bobjer J, Hagberg O, Aljabery F, Gårdmark T, Jahnson S, Jerlström T, Kjölhede H, Malmström PU, Ströck V, Söderkvist K, Ullén A, Holmberg L, Häggström C, Liedberg F. PMID: 41995252 [PubMed - indexed for MEDLINE]
	Early Initiation of novel hormonal therapy is associated with improved survival in synchronous bone-metastatic hormone-sensitive prostate cancer: a retrospective cohort study from China. Front Oncol Guo Y, Jia Y, Fan Y, Zhang W, Li Y, Li Y. PMID: 41994659 [PubMed]
	Case Report: Prostate adenocarcinoma with peritoneal carcinomatosis and elevated CEA mimicking colorectal cancer: a diagnostic dilemma. Front Oncol Majeed H, Shelman N, Patel JA, Veedu JS, Selene II, Whitesell A, Myint ZW. PMID: 41994658 [PubMed]
	Redefining standards: a comprehensive systematic review of practice changing advances in GU oncology from ASCO and ESMO 2025. Front Endocrinol (Lausanne) Ismaili N. PMID: 41993992 [PubMed - indexed for MEDLINE]
	Phase I dose-escalation study of [Â¹â·â·Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer. Theranostics Wang J, Wang R, Xiang J, Yang H, Zhao T, Guo F, Liang Y, Zhu Z, Zhang J. PMID: 41993609 [PubMed - indexed for MEDLINE]
	Apalutamide-induced severe cutaneous adverse reactions in prostate cancer: a comprehensive review of reported cases and clinical strategies. Front Pharmacol Wang T, Liu S, Yuan R. PMID: 41993591 [PubMed]
	Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAKâ€‘STAT pathway. Oncol Rep Yun Y, Ji X, Hu S, Wu T, Liu Y, Li Z, Sun Z, Zhou P, Yang L, Yu W. PMID: 41992986 [PubMed - indexed for MEDLINE]
	Novel therapeutic strategies for metastatic castrationâ€‘resistant prostate cancer: Beyond androgen receptor pathway inhibition (Review). Int J Oncol Wang Y, Xie Y, Zhao Q. PMID: 41992975 [PubMed - indexed for MEDLINE]
	Italian live Delphi consensus on indications, peri-procedural management, technique, and learning curve of convective water vapor thermal therapy (Rezumâ„¢) in men with LUTS/BPH. Urologia Secco S, Greco F, Pierella F, Tuzzolo P, Bevilacqua G, Scarciglia E, Pinto F, Rubilotta E, Cavalleri S, Abatangelo G, Lamon C, Romagnoli D, Fracalanza S, Visalli F, De Luca S, Varvello F, Renzetti R, Annunziata G, Condorelli S, Martinelli E, Marenghi C, Balsamo R, Olivero A, Castellucci R, Sountoulides P, Cindolo L. PMID: 41992701 [PubMed - as supplied by publisher]
	The role of Bladder EpiCheck(Â®) test in predicting residual tumor after transurethral resection of bladder cancer: Results from a pilot study. Urologia Pacini P, Orecchia L, Asimakopoulos AD, Manfredi M, Lavorgna S, Travaglini S, Pletto S, Abbate N, Feliciangeli V, Finazzi Agrò E, Porpiglia F, Miano R. PMID: 41992667 [PubMed - as supplied by publisher]
	Oncologic Outcomes of Cytoreductive Radical Prostatectomy in Patients With Synchronous Metastatic Castration-Sensitive Prostate Cancer: A Retrospective Analysis. Cancer Med Morozumi K, Numahata K, Oikawa M, Konno M, Kusumoto H, Akito K, Katsumata Y, Sato M, Kaiho Y. PMID: 41992568 [PubMed - indexed for MEDLINE]
	Non-invasive diagnosis strategy integrating PSMA PET/CT and mpMRI for patients with suspected prostate cancer: a multi-center study. BMC Med Wang Y, Tang Y, Chen J, Sha H, Qi L, Hu S, Chen M, Gu D, Chen S, Cai Y. PMID: 41992197 [PubMed - as supplied by publisher]
	Acute hemodialysis for cancer-associated acute kidney injury: etiologies, indications, and outcomes from a 25-year single-center experience. Ren Fail Mutis Alan A, Yalin SF, Atas I, Alan O, Altiparmak MR. PMID: 41991909 [PubMed - indexed for MEDLINE]
	Comment on "association of cardiovascular-kidney-metabolic syndrome with cardiovascular, cancer, and all-cause mortality among US adults: A prospective study". J Formos Med Assoc Arya R, Shakya H, Mohapatra AK. PMID: 41991433 [PubMed - as supplied by publisher]
	An integrated restricted mean survival time-based evaluation of efficacy, toxicity, and cost in first-line immunotherapy regimens for metastatic renal cell carcinoma. Urol Oncol Ishiyama Y, Venkatesh A, McGrath J, Rosales RDR, Kanumuambidi JP, Bandyk M, Balaji KC. PMID: 41991383 [PubMed - as supplied by publisher]

Articles 1 - 20 / 187141

Page 1 of 9358



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy